Русский

Pharmaceutical Industry Information Portal

HomeTagsGEROPHARM

All posts by tag

GEROPHARM

GEROPHARM GEROPHARM is one of the leaders in the field of biotechnology products used for diabetes treatment. Company is specializing in full-cycle drug development and production of insulin products (rh-insulins, insulin glargine, lispro & lispro mix, aspart & aspart mix, degludec).

GEROPHARM expertise also covers neurology, ophthalmology, endocrinology and gynecology therapeutic areas. GEROPHARM production facilities (two manufacturing plants) fully comply with ISO 9001 and GMP standard.

Manufacturers News

Production of Insulins under the GEROPHARM Technology Will Be Launched in Venezuela in 2025

Techno -
On 7 November 2024, Dmitriy Chernyshenko, Deputy Prime Minister of the Russian Federation, appraised the readiness of the ESPROMED BIO manufacturing site to produce...
Manufacturers News

GEROPHARM is going to develop biomedicine and pharmacology in the Russian Far East

Techno -
GEROPHARM has signed two trilateral cooperation agreements on the IX Eastern Economic Forum, which is taking place from 3 to 6 September in Vladivostok.
Manufacturers News

GEROPHARM has successfully passed Cuba’s GMP audit

Techno -
GEROPHARM received a certificate of compliance with GMP international quality standard from CECMED, the national regulatory body of Cuba.
Manufacturers News

GEROPHARM brings back Ozempic® with a new name: Semavic®

Techno -
To expand on the news about GEROPHARM's release of Semavic®, the company has introduced Semavic® as a domestic analogue to Ozempic®, responding to the cessation of Ozempic® imports from Denmark to Russia.
Manufacturers News

GEROPHARM invests 2 billion roubles in medicinal product manufacture in Saint Petersburg

Techno -
On June 16, GEROPHARM and the Government of Saint Petersburg at SPIEF-2023 signed a cooperation agreement to implement the investment project aimed at expanding the manufacture of medicinal products and increasing their export potential.
Manufacturers News

GEROPHARM will localize the production of 300 IU/mL insulin glargine in Kazakhstan

Techno -
On June 8, at the Eurasia – Our Home exhibition, GEROPHARM and Karaganda Pharmaceutical Plant signed a long-term contract to localize the production of...
12Page 1 of 2
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories